News

Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus
Merck's $3.9B SpringWorks deal, Hims & Hers' Wegovy partnership, CVS exiting Obamacare, and FDA updates on key drugs.
What is CVS? 'We are ... working through that very question'
CVS Health (CVS) is one of the largest healthcare companies in the country, boasting a vertically integrated business that ...
1 Stock to Buy, 1 Stock to Sell This Week: Palantir, Ford
Wall Street expects Palantir to earn $0.13 per share, representing a 62% year-over-year increase. Revenue is projected to ...
The Pharma Letter9h
The week in pharma: action, reaction and insight – week to May 2
US biotech Biohaven last week received a commitment from Oberland Capital to invest up to $600 million in the company. Also, ...
12 Best Stocks to Buy and Hold For 10 Years
When the stock market experiences a sharp decline, as it did after the Trump administration announced tariffs on its trade partners and China responded with retaliatory tariffs, many investors start ...